Variant Annotation ID	Variant/Haplotypes	Drug(s)	Phenotype Category	Significance	Sentence	Allele Of Frequency In Cases	Allele Of Frequency In Controls	P Value	Ratio Stat Type	Ratio Stat	Confidence Interval Start	Confidence Interval Stop
1451339660	rs10011796	allopurinol	Efficacy	no	Allele T is not associated with decreased response to allopurinol in people with Gout as compared to allele C.	T	T	= 0.017	OR	1.55	1.08	2.23
1451339660	rs10011796	allopurinol	Efficacy	no	Allele T is not associated with decreased response to allopurinol in people with Gout as compared to allele C.	T	T	= 0.59	OR	1.12	0.73	1.73
1451339600	rs2231142	allopurinol	Efficacy	yes	Allele T is associated with decreased response to allopurinol in people with Gout as compared to allele G.	T	T	= 0.00024	OR	2.51	1.56	4.18
1451339600	rs2231142	allopurinol	Efficacy	yes	Allele T is associated with decreased response to allopurinol in people with Gout as compared to allele G.	T	T	= 0.00073	OR	2.35	1.44	3.91
1451239960	rs2853542	methotrexate	Efficacy	yes	Genotype GG is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CC + CG.	G	G	= 0.02	OR	5.4	1.0	21.1
1448634144	rs6545816	hydroxyurea	Efficacy	no	Allele A is not associated with increased response to hydroxyurea in people with beta-Thalassemia.	A	A	= 0.07	OR	2.4	0.9	6.2
1448634130	rs4671393	hydroxyurea	Efficacy	yes	Allele A is associated with increased response to hydroxyurea in people with beta-Thalassemia as compared to allele G.	A	A	< 0.0001	OR	21.4	3.6	473.2
1448634124	rs766432	hydroxyurea	Efficacy	yes	Allele C is associated with increased response to hydroxyurea in people with beta-Thalassemia as compared to allele A.	C	C	< 0.001	OR	9.1	2.6	42.0
1446765784	rs1800497	bupropion	Efficacy	no	Genotypes AA + AG are not associated with response to bupropion in people with Tobacco Use Disorder as compared to genotype GG.	A	G	= 0.51	OR	0.82	0.46	1.48
1446765760	rs3211371	bupropion	Efficacy	no	Allele T is not associated with response to bupropion in people with Tobacco Use Disorder as compared to allele C.	C	T	= 0.44	OR	0.71	0.29	1.72
1446765735	rs2279343	bupropion	Efficacy	yes	Genotype AA is associated with increased response to bupropion in people with Tobacco Use Disorder as compared to genotypes AG + GG.	A	G	= 0.03	OR	1.92	1.08	3.42
981502448	rs6966038	citalopram	Efficacy	no	Allele G is associated with increased response to citalopram in people with Depressive Disorder, Major as compared to allele A.	G	G	= 0.2	OR	1.64	1.35	1.99
1451159544	rs144854329	cetuximab	Efficacy	yes	Genotype del/del is associated with increased response to cetuximab in people with Colorectal Neoplasms as compared to genotypes GGTCCCACTCTTCCCACA/GGTCCCACTCTTCCCACA + GGTCCCACTCTTCCCACA/del.	GGTCCCACTCTTCCCACA	GGTCCCACTCTTCCCACA	= 0.02	OR	10.0	1.2	100.0
1451258120	rs4673993	methotrexate	Efficacy	yes	Genotype CC is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.	C	C	= 0.007	OR	0.3	0.12	0.75
1448259816	rs1042713	salbutamol	Efficacy	no	Allele A is not associated with response to salbutamol in people with Asthma as compared to allele G.	A	A	= 0.128	OR	0.709	0.458	1.075
1448259816	rs1042713	salbutamol	Efficacy	no	Allele A is not associated with response to salbutamol in people with Asthma as compared to allele G.	A	A	= 0.215	OR	0.821	0.612	1.102
1448259816	rs1042713	salbutamol	Efficacy	no	Allele A is not associated with response to salbutamol in people with Asthma as compared to allele G.	A	A	= 0.349	OR	0.763	0.463	1.257
1448259816	rs1042713	salbutamol	Efficacy	no	Allele A is not associated with response to salbutamol in people with Asthma as compared to allele G.	A	A	= 0.843	OR	0.932	0.586	1.456
1446735619	rs2231142	sunitinib	Efficacy	no	Genotype TT is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes GG + GT.	T	G	= 0.62	OR	0.8	0.3	2.1
1451686940	rs115629050	sofosbuvir	Efficacy	no	Allele A is associated with decreased response to sofosbuvir in people with Hepatitis C, Chronic as compared to allele C.	A	A	= 0.080	OR	4.09	0.85	19.73
1451686950	rs4513095	sofosbuvir	Efficacy	yes	Allele A is associated with decreased response to sofosbuvir in people with Hepatitis C, Chronic as compared to allele C.	A	A	= 0.035	OR	5.54	1.13	27.14
1451701983	rs324026	olanzapine	Efficacy	yes	Allele C is associated with increased clinical benefit to olanzapine in people with Schizophrenia as compared to allele T.	C	C	= 0.034	OR	2.9	1.08	7.54
1451702080	rs12610827	olanzapine	Efficacy	yes	Allele T is associated with increased clinical benefit to olanzapine in people with Schizophrenia as compared to allele G.	T	T	= 0.027	OR	6.1	1.23	30.3
1451807080	rs7627954	risperidone	Efficacy	yes	Genotype CC is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CT + TT.	C	C	= 0.012	OR	0.18	0.04	0.87
1451806987	rs2088885	risperidone	Efficacy	yes	Genotype AA is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes AC + CC.	A	A	= 0.008	OR	0.17	0.04	0.8
1448634152	rs6706648	hydroxyurea	Efficacy	no	Allele T is not associated with increased response to hydroxyurea in people with beta-Thalassemia as compared to allele C.	T	T	= 0.68	OR	0.8	0.3	2.1
1449577151	rs9923231	warfarin	Efficacy	yes	Genotype CT is associated with decreased response to warfarin in people with Ventricular Dysfunction, Left as compared to genotype TT.	T	C	= 0.046	OR	4.89	1.02	36.45
1451134040	rs61734410	ethosuximide	Efficacy	yes	Allele T is associated with decreased clinical benefit to ethosuximide in children with Epilepsy as compared to allele C.	T	T	= 0.011	OR	2.63	1.25	5.56
1451134046	rs3747178	ethosuximide	Efficacy	yes	Allele T is associated with decreased clinical benefit to ethosuximide in children with Epilepsy as compared to allele C.	T	T	= 0.026	OR	2.38	1.11	5.0
1451134105	rs2753326	lamotrigine	Efficacy	yes	Allele A is associated with increased clinical benefit to lamotrigine in children with Epilepsy as compared to allele G.	A	A	= 0.038	OR	0.52	0.28	0.96
1451134060	rs2032582	lamotrigine	Efficacy	yes	Allele A is associated with decreased clinical benefit to lamotrigine in children with Epilepsy as compared to allele C.	A	A	= 0.015	OR	2.22	1.16	4.17
1449004322	rs2371108	glatiramer acetate	Efficacy	yes	Allele T is associated with increased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele G.	T	T	= 0.018	OR	2.34	1.39	3.96
1449004340	rs2114358	glatiramer acetate	Efficacy	yes	Allele A is associated with increased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele G.	A	A	= 0.045	OR	2.77	1.33	5.77
1184988665	rs2160733	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	C	A	= 0.00065	HR	1.78		
1184988665	rs2160733	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	C	A	= 0.24	HR	0.76		
1184988683	rs2160734	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele T.	C	T	= 0.00079	HR	0.57		
1184988683	rs2160734	acamprosate	Efficacy	no	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele T.	C	C	= 0.13	HR	1.31		
1451134380	rs2753325	lamotrigine	Efficacy	yes	Allele A is associated with increased clinical benefit to lamotrigine in children with Epilepsy as compared to allele G.	A	A	= 0.038	OR	0.52	0.28	0.96
1184988627	rs2058878	acamprosate	Efficacy	yes	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	A	T	= 0.024	HR	0.49		
1184988627	rs2058878	acamprosate	Efficacy	yes	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	A	T	= 0.068	HR	0.72		
1447674849	rs1570360	cetuximab	Efficacy	yes	Genotype GG is associated with increased response to cetuximab in people with Colorectal Neoplasms as compared to genotypes AA + AG.	A	A	= 0.015	OR	5.0	1.4	16.5
1447674843	rs833061	cetuximab	Efficacy	yes	Genotype TT is associated with increased response to cetuximab in people with Colorectal Neoplasms as compared to genotypes CC + CT.	C	C	= 0.02	OR	10.0	1.2	100.0
1449004923	rs4244285	cyclophosphamide	Efficacy	yes	Genotypes AG + GG is associated with decreased response to cyclophosphamide in people with Lupus Nephritis as compared to genotype AA.	G	G	= 0.0043	OR	2.69	1.36	5.32
1449004932	rs776746	cyclophosphamide	Efficacy	no	Genotype TT is associated with decreased response to cyclophosphamide in people with Lupus Nephritis as compared to genotypes CC + CT.	T	T	= 0.64	OR	0.76	0.31	31.85
1449004938	rs1695	cyclophosphamide	Efficacy	no	Genotypes AG + GG is associated with decreased response to cyclophosphamide in people with Lupus Nephritis as compared to genotype AA.	G	G	= 0.03	OR	2.8	1.15	16.9
1185234906	rs1803274	rivastigmine	Efficacy	yes	Genotypes CT + TT is associated with decreased response to rivastigmine in people with Alzheimer Disease as compared to genotype CC.	C	T	= 0.016	OR	0.35	0.14	0.87
1449181943	rs8636	amisulpride	Efficacy	yes	Genotype CT is associated with increased response to amisulpride in people with Schizophrenia as compared to genotypes CC + TT.	C	C	= 0.027	OR	3.97	1.42	11.11
1449181943	rs8636	amisulpride	Efficacy	yes	Genotype CT is associated with increased response to amisulpride in people with Schizophrenia as compared to genotypes CC + TT.	C	C	= 0.053	OR	2.91	1.2	7.09
1444843016	rs10305420	liraglutide	Efficacy	yes	Genotypes CT + TT are associated with decreased response to liraglutide in women with Obesity and Polycystic Ovary Syndrome as compared to genotype CC.	C	T	= 0.025	OR	0.27	0.09	0.85
1184166985	rs6822844	rituximab	Efficacy	yes	Genotype GG is associated with increased response to rituximab in people with Autoimmune Diseases as compared to genotype GT.	G	G	= 0.024	OR	3.53	1.06	11.64
1184166985	rs6822844	rituximab	Efficacy	yes	Genotype GG is associated with increased response to rituximab in people with Autoimmune Diseases as compared to genotype GT.	G	G	= 0.683	OR	1.0	0.02	10.67
1444842903	rs6923761	liraglutide	Efficacy	no	Genotypes AA + AG are associated with increased response to liraglutide in women with Obesity and Polycystic Ovary Syndrome as compared to genotype GG.	A	G	= 0.058	OR	3.06	0.96	9.74
1448266279	rs6878291	platinum	Efficacy	yes	Genotype GG is associated with decreased response to platinum in people with Carcinoma, Non-Small-Cell Lung as compared to genotype AA.	G	G	= 0.001	OR	2.04	1.35	3.07
1448102401	rs4291	sertraline	Efficacy	no	Genotype TT is not associated with response to sertraline in people with Depressive Disorder.	T	T	= 0.803	OR	1.41	0.84	2.53
1448266217	rs12995526	methotrexate	Efficacy	yes	Genotypes CT + TT is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	C	C	= 0.001	OR	0.23	0.1	0.53
1448266210	rs7563206	methotrexate	Efficacy	yes	Genotypes CT + TT is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	C	C	< 0.001	OR	0.2	0.09	0.46
1448266196	rs2372536	methotrexate	Efficacy	yes	Genotypes CC + CG is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.	C	C	= 0.036	OR	0.27	0.08	0.92
1448266203	rs4673993	methotrexate	Efficacy	yes	Genotypes CT + TT is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	C	C	= 0.036	OR	0.27	0.08	0.92
1448266186	rs1801394	methotrexate	Efficacy	yes	Genotypes AA + AG is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.	A	A	= 0.041	OR	2.16	1.03	4.53
1448102319	rs1799752	sertraline	Efficacy	yes	Genotype del/del is associated with increased response to sertraline in people with Depressive Disorder.	del	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	= 0.0006	OR	3.03	1.08	5.08
1448266150	rs1805087	methotrexate	Efficacy	yes	Genotype AA is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A	A	= 0.017	OR	0.42	0.2	0.86
1448266111	rs1801133	methotrexate	Efficacy	yes	Genotype AA is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	A	A	= 0.019	OR	3.86	1.25	11.89
1448266104	rs1801131	methotrexate	Efficacy	yes	Genotype TT is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes GG + GT.	T	T	= 0.045	OR	0.51	0.26	0.98
1451104640	rs3781719	botulinum toxin type a	Efficacy	yes	Allele G is associated with decreased response to botulinum toxin type a in women with Migraine NOS as compared to allele A.	G	G	= 0.029	OR	1.88	1.06	3.32
1450367980	rs5333	prednisone	Efficacy	yes	Genotypes CC + CT is associated with increased resistance to prednisone in children with Nephrotic Syndrome as compared to genotype TT.	C	C	= 0.016	OR	2.74	1.2	6.27
1449270432	rs1495741	iguratimod	Efficacy	yes	Genotypes AG + GG is associated with decreased clinical benefit to iguratimod in people with Arthritis, Rheumatoid as compared to genotype AA.	G	G	= 0.039	OR	0.498	0.256	0.967
1449270454	rs2032582	iguratimod	Efficacy	yes	Genotypes CT + TT is associated with increased clinical benefit to iguratimod in people with Arthritis, Rheumatoid as compared to genotype CC.	T	T	= 0.023	OR	2.041	1.093	3.811
1449270444	rs2231142	iguratimod	Efficacy	yes	Genotypes GT + TT is associated with increased clinical benefit to iguratimod in people with Arthritis, Rheumatoid as compared to genotype GG.	T	T	= 0.038	OR	1.944	1.038	3.641
1448432602	rs2372536	methotrexate	Efficacy	yes	Genotype GG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CC + CG.	G	G	= 0.005	OR	2.4	1.3	4.42
1446695874	rs2305948	sunitinib	Efficacy	no	Genotype CT is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotype CC.	T	C	= 0.16	OR	0.5	0.2	1.3
1447678493	rs1045642	carbamazepine	Efficacy	no	Genotype GG is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AA + AG.	G	A	= 0.91	OR	1.06	0.421	2.643
1447678481	rs3812718	carbamazepine	Efficacy	no	Genotype CC is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes CT + TT.	C	T	= 0.97	OR	0.47	2.045	
1447678447	rs2234922	carbamazepine	Efficacy	no	Genotype AA is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes AG + GG.	A	G	= 0.79	OR	1.05	0.543	2.228
1447678435	rs1051740	carbamazepine	Efficacy	no	Genotype TT is not associated with resistance to carbamazepine in people with Epilepsy as compared to genotypes CC + CT.	C	T	= 0.97	OR	0.98	0.47	2.045
1450811579	rs1128503	methadone	Dosage	yes	Genotype AA is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes AG + GG.	A	A	= 0.0325	OR	6.66	1.41	31.36
1449005441	rs1045642	imatinib	Efficacy	no	Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.	G	A	= 0.21	OR	0.62	0.28	1.34
1444667028	rs1063538	pioglitazone	Efficacy	no	Genotypes CC + CT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	C	T	= 0.765	OR	1.255	0.283	5.62
1444666932	rs266729	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CG + GG.	G	C	= 0.856	OR	1.219	0.156	9.352
1444666944	rs16861194	pioglitazone	Efficacy	no	Genotype AG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.	G	A	= 0.781	OR	1.274	0.231	7.019
1444666960	rs1063537	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	C	T	= 0.235	OR	2.972	0.492	17.947
1444666966	rs2082940	pioglitazone	Efficacy	no	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	C	T	= 0.719	OR	1.303	0.308	5.515
1444666874	rs1501299	pioglitazone	Efficacy	no	Genotypes GT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	G	T	= 0.461	OR	1.718	0.408	7.23
1449645155	rs316019	metformin	Efficacy	yes	Genotypes AA + AC is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	A	A	= 0.0064	OR	0.35	0.16	0.77
827816679	rs2107506	lithium	Efficacy	no	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	C	C	= 0.2208	OR	1.27	0.82	1.95
1449645164	rs12943590	metformin	Efficacy	yes	Genotypes AA + AG is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to genotype GG.	A	A	= 0.19	OR	0.68	0.38	1.22
1444666816	rs2241766	pioglitazone	Efficacy	yes	Genotype GT is associated with increased response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	G	T	= 0.001	OR	11.483	2.637	50.002
827816646	rs1390913	lithium	Efficacy	no	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	A	A	= 0.712	OR	1.11	0.69	1.81
827816637	rs2811332	lithium	Efficacy	no	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	C	C	= 0.1658	OR	1.36	0.88	2.09
827816630	rs12693402	lithium	Efficacy	no	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	C	C	= 0.53	OR	1.25	0.58	2.65
827816621	rs11869731	lithium	Efficacy	yes	Genotype CC is associated with increased response to lithium in people with Bipolar Disorder as compared to genotypes CG + GG.	C	C	= 4.7E-4	OR	2.39	1.46	3.89
981349362	rs699947	sildenafil	Efficacy	yes	Genotypes AA + AC are associated with decreased response to sildenafil in men with Erectile Dysfunction as compared to genotype CC.	A	A	= 0.016	OR	2.26	0.92	5.54
981349362	rs699947	sildenafil	Efficacy	yes	Genotypes AA + AC are associated with decreased response to sildenafil in men with Erectile Dysfunction as compared to genotype CC.	A	A	= 0.031	OR	2.81	1.12	7.06
1450809598	rs5443	sibutramine	Efficacy	yes	Genotype CC is associated with increased response to sibutramine in people with Obesity as compared to genotypes CT + TT.	T	T	= 0.004	OR	6.8	1.8	25.6
1450809598	rs5443	sibutramine	Efficacy	yes	Genotype CC is associated with increased response to sibutramine in people with Obesity as compared to genotypes CT + TT.	T	T	= 0.01	OR	9.6	1.7	53.8
1448519661	rs1731017	valproic acid	Efficacy	no	Genotypes AA + AG is associated with increased resistance to valproic acid in people with Epilepsy as compared to genotype GG.	A	A	= 0.120	OR	2.795	1.366	5.72
1450928217	rs1805054	risperidone	Efficacy	no	Allele T is not associated with response to risperidone in people with Schizophrenia as compared to allele C.	T	T	= 1	OR	0.965	0.731	1.273
1450928217	rs1805054	risperidone	Efficacy	no	Allele T is not associated with response to risperidone in people with Schizophrenia as compared to allele C.	T	T	= 1	OR	1.05	0.761	1.449
1450928217	rs1805054	risperidone	Efficacy	no	Allele T is not associated with response to risperidone in people with Schizophrenia as compared to allele C.	T	T	= 1	OR	0.973	0.501	1.891
1450928312	rs9606186	risperidone	Efficacy	no	Allele C is not associated with response to risperidone in people with Schizophrenia as compared to allele G.	C	C	= 0.511	OR	0.816	0.615	1.081
1450928312	rs9606186	risperidone	Efficacy	no	Allele C is not associated with response to risperidone in people with Schizophrenia as compared to allele G.	C	C	= 0.511	OR	0.387	0.164	0.91
1450928312	rs9606186	risperidone	Efficacy	no	Allele C is not associated with response to risperidone in people with Schizophrenia as compared to allele G.	C	C	= 1	OR	0.869	0.634	1.192
1184166980	rs6822844	rituximab	Efficacy	yes	Genotype GG is associated with increased response to rituximab in people with Lupus Erythematosus, Systemic as compared to genotype GT.	G	G	= 0.016	OR	6.43	1.42	21.07
981502459	rs809736	citalopram	Efficacy	no	Allele G is associated with increased response to citalopram in people with Depressive Disorder, Major as compared to allele A.	G	G	= 3.5	OR	1.52	1.27	1.83
1446754341	rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	= 0.07	HR	1.7	1.0	3.1
1446754341	rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	= 0.09	HR	1.7	0.9	3.2
1446754341	rs1128503	sunitinib	Efficacy	no	Genotype AA is not associated with response to sunitinib in people with Carcinoma, Renal Cell as compared to genotypes AG + GG.	G	A	= 0.13	OR	0.5	0.2	1.3
1444666926	rs3774261	pioglitazone	Efficacy	no	Genotypes AG + GG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.	G	A	= 0.856	OR	1.209	0.156	9.352
1444666909	rs2241767	pioglitazone	Efficacy	no	Genotype AA are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes AG + GG.	G	A	= 0.826	OR	1.201	0.236	6.12
1444666920	rs3821799	pioglitazone	Efficacy	no	Genotypes CT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype CC.	C	T	= 0.908	OR	1.131	0.139	9.204
1450928150	rs4633	risperidone	Efficacy	no	Allele T is associated with decreased response to risperidone in people with Schizophrenia as compared to allele C.	T	T	> 0.05	OR	3.56	1.24	10.21
1450928225	rs2494732	risperidone	Efficacy	no	Allele T is not associated with response to risperidone in people with Schizophrenia as compared to allele C.	T	T	= 1	OR	0.923	0.703	1.211
1450928225	rs2494732	risperidone	Efficacy	no	Allele T is not associated with response to risperidone in people with Schizophrenia as compared to allele C.	T	T	= 1	OR	1.038	0.759	1.419
1450928225	rs2494732	risperidone	Efficacy	no	Allele T is not associated with response to risperidone in people with Schizophrenia as compared to allele C.	T	T	= 1	OR	0.707	0.358	1.395
1450928170	rs1176713	risperidone	Efficacy	no	Allele G is not associated with response to risperidone in people with Schizophrenia as compared to allele A.	G	G	= 1	OR	0.983	0.743	1.3
1450928170	rs1176713	risperidone	Efficacy	no	Allele G is not associated with response to risperidone in people with Schizophrenia as compared to allele A.	G	G	= 1	OR	1.165	0.84	1.615
1450928170	rs1176713	risperidone	Efficacy	no	Allele G is not associated with response to risperidone in people with Schizophrenia as compared to allele A.	G	G	= 1	OR	0.819	0.419	1.603
1448634117	rs1427407	hydroxyurea	Efficacy	yes	Allele T is associated with increased response to hydroxyurea in people with beta-Thalassemia as compared to allele G.	T	T	< 0.01	OR	6.1	1.9	23.1
1449004334	rs6498169	glatiramer acetate	Efficacy	yes	Allele A is associated with increased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele G.	A	A	= 0.024	OR	2.86	1.42	5.75
1449005435	rs2032582	imatinib	Efficacy	no	Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.	G	A	= 0.28	OR	0.57	0.3	1.43
1450928201	rs1800497	risperidone	Efficacy	no	Allele A is not associated with response to risperidone in people with Schizophrenia as compared to allele G.	A	A	= 1	OR	0.989	0.741	1.321
1450928201	rs1800497	risperidone	Efficacy	no	Allele A is not associated with response to risperidone in people with Schizophrenia as compared to allele G.	A	A	= 1	OR	0.974	0.709	1.338
1450928201	rs1800497	risperidone	Efficacy	no	Allele A is not associated with response to risperidone in people with Schizophrenia as compared to allele G.	A	A	= 1	OR	0.845	0.378	1.887
1451104645	rs222749	botulinum toxin type a	Efficacy	yes	Allele A is associated with decreased response to botulinum toxin type a in women with Migraine NOS as compared to allele G.	A	A	= 0.021	OR	3.29	1.28	8.43
1448102384	rs4343	sertraline	Efficacy	no	Genotype GG is not associated with response to sertraline in people with Depressive Disorder.	G	G	= 0.999	OR	1.13	0.68	1.88
981349353	rs1570360	sildenafil	Efficacy	yes	Genotype AA is associated with decreased response to sildenafil in men with Erectile Dysfunction as compared to genotypes AG + GG.	A	A	< 0.001	OR	8.5	2.34	30.92
981349353	rs1570360	sildenafil	Efficacy	yes	Genotype AA is associated with decreased response to sildenafil in men with Erectile Dysfunction as compared to genotypes AG + GG.	A	A	= 0.008	OR	19.93	1.13	350.0
827816749	rs2826494	lithium	Efficacy	no	Allele G is associated with response to lithium in people with Bipolar Disorder as compared to allele C.	G	G	= 0.0019	OR	2.07	1.3	3.29
1448617505	rs3745274	efavirenz	Efficacy	yes	Genotypes GT + TT are associated with decreased resistance to efavirenz in people with HIV Infections as compared to genotype GG.	T	T	= 0.03	OR	0.7	0.5	0.97
